Millennium Management’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$579K Buy
793,948
+680,774
+602% +$3.1M ﹤0.01% 4688
2025
Q4
$632K Buy
113,174
+27,613
+32% +$307K ﹤0.01% 4796
2025
Q3
$631K Buy
85,561
+11,159
+15% +$94.8K ﹤0.01% 4934
2025
Q2
$567K Sell
74,402
-2,314
-3% -$36K ﹤0.01% 4818
2025
Q1
$1.46M Sell
76,716
-13,508
-15% -$425K ﹤0.01% 4069
2024
Q4
$3.27M Sell
90,224
-1,417
-2% -$39.5K ﹤0.01% 3215
2024
Q3
$2.64M Buy
91,641
+29,566
+48% +$657K ﹤0.01% 3442
2024
Q2
$1.59M Buy
62,075
+19,345
+45% +$879K ﹤0.01% 3732
2024
Q1
$3.23M Buy
42,730
+2,635
+7% +$209K ﹤0.01% 3298
2023
Q4
$4.13M Buy
40,095
+18,938
+90% +$1.7M ﹤0.01% 2947
2023
Q3
$2.06M Sell
21,157
-1,827
-8% -$170K ﹤0.01% 3522
2023
Q2
$2.69M Buy
22,984
+21,062
+1,096% +$2.67M ﹤0.01% 3218
2023
Q1
$161K Buy
+1,922
New +$168K ﹤0.01% 5260
2021
Q2
Sell
-1,766
Closed -$203K 7030
2021
Q1
$203K Buy
+1,766
New +$295K ﹤0.01% 5491

Other funds holding RVPH

Millennium Management's RVPH Position: Q1 2026 in Review

Millennium Management increased its REVIVA PHARMA HLDGS INC (RVPH) stake by 602% in Q1 2026, buying an estimated $3.1M and bringing the position to 793,948 shares worth $579K. The position accounts for ﹤0.01% of the portfolio, ranked #4688.

Millennium Management first reported a position in RVPH in Q1 2021 and has held it in 14 quarters since. The position peaked at $4.13M in Q4 2023. 35 funds tracked by Wall St. Rank hold RVPH as of Q1 2026.

  • Millennium Management held 793,948 shares of REVIVA PHARMA HLDGS INC worth $579K as of Q1 2026.
  • Millennium Management bought 680,774 REVIVA PHARMA HLDGS INC shares in Q1 2026, an estimated $3.1M.
  • REVIVA PHARMA HLDGS INC made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #4688 holding.
  • Millennium Management first reported a position in REVIVA PHARMA HLDGS INC in Q1 2021 and has held it in 14 quarters since.
  • Millennium Management's REVIVA PHARMA HLDGS INC position peaked at $4.13M in Q4 2023.
  • 35 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.